OnabotulinumtoxinA


( Last Updated : August 15, 2013)
Generic Name:
OnabotulinumtoxinA
Project Status:
Complete
Therapeutic Area:
Migraine
Manufacturer:
Allergan Inc.
Call for patient/clinician input open:
Brand Name:
Botox
Project Line:
Reimbursement Review
Project Number:
SR0345-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC

Details


Submission Type:
Initial
Indications:
Migraine, chronic
Recommendation Type:
Do not list
Final Recommendation: